FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Pfizer Us Pharmaceutical Group Pristiq Recall

Pristiq (desvenlafaxine) Extended-Release Tablets 50 mg, 30 count bottle, Rx only, Dist…

Pfizer Us Pharmaceutical Group · New York, NY

Risk level
Class II
Reported by FDA
Jul 2, 2014
Recall ID
D-1409-2014
Check your lot numberHow we source this data

Summary

Pfizer Us Pharmaceutical Group recalled Pristiq starting Apr 16, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1409-2014 on Jul 2, 2014. Reason: Presence of Foreign Tablets/Capsules: Pfizer is recalling 50 mg Pristiq (desvenlafaxine) extended release tablets because a single Pristiq 100 mg tablet was found in a bottle of 50 mg Pristiq. Status: Terminated.

Why it was recalled

Presence of Foreign Tablets/Capsules: Pfizer is recalling 50 mg Pristiq (desvenlafaxine) extended release tablets because a single Pristiq 100 mg tablet was found in a bottle of 50 mg Pristiq.

Product description

Pristiq (desvenlafaxine) Extended-Release Tablets 50 mg, 30 count bottle, Rx only, Distributed by Wyeth Pharmaceuticals, Inc., NDC 0008-1211-30

Lot numbers, UPCs & expiration codes

H74477, H74478, Exp. 03/16, H74479, H79766 Exp. 05/16

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1409-2014
Classification
Class II
Status
Terminated
Recall initiated
Apr 16, 2014
FDA report date
Jul 2, 2014
Quantity
220,761 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Pfizer Us Pharmaceutical Group

Original FDA data

Every field from FDA enforcement report D-1409-2014, exactly as published.

Show all FDA fields
City
New York
State
NY
Status
Terminated
Country
United States
Event ID
68001
Address
235 E 42nd St
Code information
H74477, H74478, Exp. 03/16, H74479, H79766 Exp. 05/16
Postal code
10017-5703
Report date
Jul 2, 2014
Product type
Drugs
Recall number
D-1409-2014
Classification
Class II
Recalling firm
Pfizer Us Pharmaceutical Group
Product quantity
220,761 bottles
Termination date
Sep 20, 2016
Reason for recall
Presence of Foreign Tablets/Capsules: Pfizer is recalling 50 mg Pristiq (desvenlafaxine) extended release tablets because a single Pristiq 100 mg tablet was found in a bottle of 50 mg Pristiq.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Pristiq (desvenlafaxine) Extended-Release Tablets 50 mg, 30 count bottle, Rx only, Distributed by Wyeth Pharmaceuticals, Inc., NDC 0008-1211-30
Distribution pattern
Nationwide
Recall initiation date
Apr 16, 2014
Initial firm notification
Letter
Center classification date
Jun 24, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1409-2014, published Jul 2, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls